01/03/2017 - 1:36pm
Forbes is reporting that the Food and Drug Administration’s approval of 22 new drugs in 2016 (down from 51 in 2015) could have big implications for the future of innovation in the pharmaceutical space. The report notes that research spending is growing, but there are practical difficulties to translate innovation into products as R&D returns decline  — and the report suggests overcoming that difficulty could mean rethinking a lot. (Forbes)
12/27/2016 - 12:46pm

Novo Nordisk accused of issuing marketing materials asking patients and doctors to switch from Sanofi’s Lantus and Toujeo drugs to Tresiba, because the Sanofi drugs will be “blocked” by CVS Caremark in January.

12/27/2016 - 10:13am

Spinraza treats SMA, a rare and often fatal genetic disease affecting muscle strength and movement.

12/22/2016 - 8:02am

Dexcom’s G5 Mobile allows for testing for diabetes treatment decisions in people 2 years of age and older with diabetes.

12/21/2016 - 11:45am

Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.

12/21/2016 - 11:41am

Systemic inflammatory conditions combined affect more than 2 million Americans.

12/16/2016 - 3:22pm

Removal based on the outcomes of EAGLES, the largest smoking cessation clinical trial in patients without and with a history of psychiatric disorder.

12/15/2016 - 2:57pm

Expanding by 13 the list of vaccinations that can be administered to patients is part of the province's new strategy, Immunization 2020, which focuses on improving access to immunizations.

12/15/2016 - 2:43pm

Walgreens ranks the top markets and states for flu activity in the U.S. It's the third year for Walgreens' Flu Index, and this year will include Puerto Rico for the first time.